Cashu | Summary

DJI

+0.08%

SPX

-0.22%

IXIC

-0.51%

FTSE

-0.20%

N225

-0.22%

AXJO

-0.21%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

+0.08%

SPX

-0.22%

IXIC

-0.51%

FTSE

-0.20%

N225

-0.22%

AXJO

-0.21%

HomeWatchlistNewsSignalsPicks

Overview

Loading chart...

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Overview

Loading chart...

Join our newsletter to keep up to date with us!

Key Stats

Market Cap

104.30M

Dividend Yield

0.00%

P/E Ratio

NaN

EPS

-0.18

Revenue

Avg. Volume

About

What does MSCL.TO do?

Satellos Bioscience, a Toronto-based regenerative medicine company, focuses on developing therapeutics for muscle diseases using its MyoReGenX platform. Its lead program targets Duchenne muscular dystrophy with an oral small molecule drug candidate.

Sector

💻 Health Care

IPO

CEO

Employees

Headquarters

Website

https://satellos.com

Recently from Cashu

Cashu

Satellos Bioscience Inc. Showcases Muscle Disease Research at PPMD Conference 2025

3 days ago

Cashu

Satellos Bioscience Inc. Advances SAT-3247 for Promising Duchenne Muscular Dystrophy Treatment

28 days ago

Cashu

Satellos Bioscience Inc. Boosts Investor Relations with $1.6M Warrant Exercise by Bloom Burton

29 days ago

Stocks

Health Care

mscl.to

Satellos Bioscience Inc

TO: MSCL.TO

0.00 (0.00%)

0.55

USD

At close at Jun 21, 24:39 UTC